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Background: DsbA is a master virulence determinant of bacterial pathogens and a target for antivirulence drugs.
Results:AbDsbA is a class I dithiol oxidase that binds EF-Tu-derived and DsbB-derived peptides on different enzyme surfaces.
Conclusion: Discovery of high affinity peptide interaction sites provides a platform for inhibitor design.
Significance: AbDsbA inhibitors could have anti-biofilm activity against multidrug resistant Acinetobacter baumannii.
The multidrug resistant bacterium Acinetobacter baumannii
is a significant cause of nosocomial infection. Biofilm formation,
that requires both disulfide bond forming and chaperone-usher
pathways, is a major virulence trait in this bacterium. Our bio-
chemical characterizations show that the periplasmic A. bau-
mannii DsbA (AbDsbA) enzyme has an oxidizing redox poten-
tial and dithiol oxidase activity. We found an unexpected
non-covalent interaction between AbDsbA and the highly con-
served prokaryotic elongation factor, EF-Tu. EF-Tu is a cyto-
plasmic protein but has been localized extracellularly in many
bacterial pathogens. The crystal structure of this complex
revealed that the EF-Tu switch I region binds to the non-cata-
lytic surface of AbDsbA. Although the physiological and patho-
logical significance of a DsbA/EF-Tu association is unknown,
peptides derived from the EF-Tu switch I region bound to
AbDsbA with submicromolar affinity. We also identified a sev-
en-residue DsbB-derived peptide that bound to AbDsbA with
low micromolar affinity. Further characterization confirmed
that the EF-Tu- and DsbB-derived peptides bind at two distinct
sites. These data point to the possibility that the non-catalytic
surface of DsbA is a potential substrate or regulatory protein
interaction site. The two peptides identified in this work
together with the newly characterized interaction site provide a
novel starting point for inhibitor design targeting AbDsbA.
The global increase inmultidrug- or pandrug-resistantAcin-
etobacter baumannii infections poses a major risk to public
health. A. baumannii is one of the “ESKAPE” pathogens
(Enterococcus faecium, Staphylococcus aureus,Klebsiella pneu-
moniae, Pseudomonas aeruginosa, and Enterobacter species),
so-called because of their ability to “escape” the effects of clin-
ically useful antibiotics by biofilm formation and rapid acquisi-
tion of resistance genes (1). Collectively, these ESKAPE patho-
gens are a major cause of hospital- and community-acquired
infections, morbidity, andmortality. New targets and strategies
are needed to combat infections caused by these pathogens.
A. baumannii (colloquially known as Iraqibacter) is a Gram-
negative, opportunistic pathogen that can cause a wide range of
diseases, including pneumonia,meningitis, bacteremia, urinary
tract infections, and wound infections (2, 3). This microbe has
been responsible for multiple outbreaks around the world,
including Australia and among United States military personal
deployed in the Middle East (5–9). There is a high incidence of
A. baumannii infection among immunocompromised patients,
especially those who have experienced long stays in hospital
(10). Multidrug-resistant A. baumannii such as the AYE strain
have accumulated a large cluster of resistance genes via hori-
zontal gene transfer. Both itsmultidrug resistance and its ability
to survive on highly desiccated abiotic surfaces (e.g. plastic and
glass medical devices) have been linked to its success as a nos-
ocomial pathogen (11, 12). Currently, there is no vaccine
against A. baumannii (4).
A. baumannii can invade host cells, but little is known
about its pathogenic mechanism. Biofilm formation is a
major virulence trait contributing to bacterial colonization
on tissue and persistence in the hospital environment (13).
Electron and fluorescence microscopy experiments showed
that cell surface fimbriae are necessary for A. baumannii
attachment and initiation of biofilm formation on abiotic
and biotic surfaces (14). Fimbriae are filamentous, multisub-
unit protein assemblies. Each fimbrial subunit contains an
evolutionarily invariant disulfide bridge (15) that requires
both the oxidative folding and the chaperone-usher path-
ways for assembly (13, 14, 16, 17).
Theatomic coordinates and structure factors (code4P3Y) havebeendeposited in
the Protein Data Bank (http://wwpdb.org/).
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The disulfide bond-forming system of Gram-negative bacte-
ria typically comprises DsbA (a soluble, periplasmic, thiore-
doxin-fold dithiol oxidoreductase) and DsbB (an integral inner
membrane protein). DsbA catalyzes the formation of disulfide
bonds in nascent substrate proteins as they are translocated
into the periplasm. Through this reaction, the active site CXXC
motif of DsbA becomes reduced and is restored to its function-
ally competent oxidized state through interaction with DsbB.
DsbA is considered a master regulator of virulence and viru-
lence traits (14, 18–21). Deletion or mutation of dsbA attenu-
ates virulence factor maturation in bacterial pathogens includ-
ing Proteus mirabilis (22), uropathogenic Escherichia coli (23),
Burkholderia pseudomallei (24), Vibrio cholerae (25), Shigella
flexneri (26), and Salmonella enterica serovar typhimurium
(27). DsbA inhibitors are potential anti-virulence drugs (28).
Here we characterize DsbA from A. baumannii (AbDsbA)6
and show that it has an unusually basic surface, with redox and
catalytic properties that qualify it as a bona fide dithiol oxidase.
We also report an unexpected interaction between AbDsbA
and E. coli EF-Tu (EcEF-Tu); the complex can be co-purified
from the cytoplasm of the E. coli expression system. This ser-
endipitous discovery allowed the crystal structure determina-
tion of the AbDsbAEcEF-Tu complex at 2.15 Å resolution and
identification of specific intermolecular interactions.
Although the highly conserved EF-Tu is generally considered
to be a cytoplasmic protein, extracellular localization has been
reported in bacterial pathogens including A. baumannii (29),
P. aeruginosa (30, 31), and Mycobacterium tuberculosis (32).
Moreover, EF-Tu has been found to bind human fibronectin,
platelet-activating factor receptor, plasminogen, and factor H
for adhesion, tissue infiltration, and complement system inac-
tivation. Intracellularly, EF-Tu has functions additional to its
central role in protein translation. For example, inBacillus sub-
tilis EF-Tu plays a role in cell shape by interacting with actin-
like proteins (33). Bacteriophages Q and T4 both recruit
EF-Tu to perform essential functions (34, 35). We investigated
the interaction by generating peptides derived from EF-Tu and
showed that these bind tightly toAbDsbA, providing a platform
for the future design of peptidomimetic inhibitors targeting
AbDsbA.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—A codon-optimized
synthetic gene coding for A. baumannii (AYE strain) DsbA
(amino acids 27–205; Uniprot: B0V5X3) lacking the predicted
periplasmic leader sequence (amino acids 1–22) was cloned
into the pMCSG7 (36) plasmid to enable expression in the bac-
terial cytoplasm. This expression construct was alsomutated to
the A. baumannii (SDF strain) DsbA using the QuikChange
(Agilent) procedure. These two natural DsbA variants differ by
a single amino acid at the CXXC catalytic motif (CPHC in AYE
strain and CPLC in SDF strain).
AbDsbA proteins were expressed in BL21(DE3) cells using
autoinduction (37). Cell pellets were resuspended in 50 mM
Tris, pH 8.0, 100 mM NaCl and lysed in a Cell Disruptor (TS-
Series, Constant Systems LTD.). Cell debris was removed by
centrifugation. The supernatant was loaded onto Talon resin
(Clontech), packed in a disposable gravity column, and equili-
brated with 50 mM Tris, pH 8.0, 100 mM NaCl. Unbound pro-
teins were removed with washing buffer (50 mM Tris, pH 8.0,
100 mM NaCl, 10% glucose, and 10% sucrose). Elution was
achieved using wash buffer containing 300mM imidazole. SDS-
PAGE analysis of eluent fractions revealed that AbDsbA co-
eluted with a second protein, identified as E. coli EF-Tu using
mass spectrometry analysis (see below). The His6 affinity tag
was removed by tobacco etch virus protease, leaving three vec-
tor-borne residues (Ser-Asn-Ala) at theN terminus ofAbDsbA.
The AbDsbAEF-Tu complex was further purified using a
Superdex S200 gel-filtration column (GEHealthcare). For puri-
fication of AbDsbA free from EF-Tu, the above procedure was
modified to a batch purification step with Talon resin and
repeated high salt wash (50 mM Tris, pH 8.0, 1.0 M NaCl).
EcDsbA and E. coli membrane extracts containing overex-
pressed E. coliDsbB (EcDsbB) were prepared as described pre-
viously (38) and resuspended in phosphate-buffered saline con-
taining 10% glycerol.
Protein Identification by Mass Spectrometry—Coomassie-
stained bands corresponding to AbDsbA (21 kDa) and a 40-
kDa endogenous E. coli protein were cut from SDS-PAGE and
subjected to in-gel tryptic digestion as described previously
(39). The extracted peptides were applied to the MALDI target
plate with -cyano-4-hydroxycinnamic acid matrix. MS spec-
tra were recorded in positive reflector mode at a laser energy of
3200 using a 4700 Proteomics Analyzer MALDI TOF-TOF
(Applied Biosystems, CA). AllMS/MS data from the TOF-TOF
were acquired using the default positive ion, 1-kV collision
energy, at a laser energy of 4400. Thirteen dominant species
from the MALDI-MS data for the E. coli protein were queried
against the SwissProt E. coli database with a tolerance of 0.2 Da
using the MASCOT Peptide Mass Fingerprint server (Matrix
Science). The top hit from the search indicated that the
unknown protein was EF-Tu. In addition, MALDI TOF-TOF
data were used to identify a 2117.2 m/z species as the peptide
AIDKPFLLPIEDVFSISGR, an EF-Tu tryptic peptide. The band
corresponding to 21 kDa was confirmed as AbDsbA by com-
parison of the MALDI-MS species detected in its tryptic digest
with those expected to arise from the tryptic digestion of
AbDsbA.
Crystallization and Structure Determination—AbDsbAEF-Tu
complex crystals were grown at 20 °C by setting drops with 250
nl of protein solution (10 mg/ml in 25 mM HEPES, pH 7.4, and
100 mMNaCl) and 250 nl of precipitant solution (200–300 mM
KCl and 4.5–6% PEG 3350) using a Mosquito robot (TTP
Labtech) at the University of Queensland Remote Operation
Crystallization and X-ray (ROCX) diffraction facility. Crystals
were cryoprotected (in 250mMKCl, 30mMHEPES, pH7.4, 15%
PEG3350, and 25% glycerol) and flash-frozen in liquid nitrogen.
Diffraction data from the cryo-cooled crystal were collected at
the Australian Synchrotron MX2 beamline with an ADSC
Quantum 315r detector controlled by BLU-ICE (40). Reflec-
tions were indexed and integrated in XDS (41), analyzed in
6 The abbreviations used are: AbDsbA, A. baumannii DsbA; EcDsbB; E. coli
DsbB; Bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-
1,3-diol; ITC, isothermal titration calorimetry; EF-Tu, elongation factor Tu;
EcEF-Tu, E. coli EF-Tu; AbEF-Tu, A. baumannii EF-Tu.
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Pointless (42), and scaled in SCALA (42) from the CCP4 suite
(43).
Cell content analysis indicated one copy of AbDsbAEF-Tu
complex in the crystallographic asymmetric unit. Molecular
replacement using E. coli EF-Tu (PDB ID 1EFC), truncated into
its three individual domains, yielded a solution in PHASER (44).
The initial electron densitymap after Phenix refinement guided
the location ofAbDsbAand allowed tracing 33%of theAbDsbA
sequence (59 of 178 residues). Iterativemanual rebuilding, den-
sity modification, and refinement in PHENIX (45) and COOT
(46) permitted tracing the entire AbDsbA sequence. Density
corresponding to bound diphosphate nucleoside (GDP) and
Mg2wasmodeled in the guanosine binding domain of EF-Tu.
The first seven residues of EF-Tu and the last residue of
AbDsbA were not modeled due to a lack of electron density in
these regions. The final R-factor/R-free was 17.2%/21.5%. Data
processing and refinement statistics are provided in Table 1.
The coordinates and structure factors have been deposited to
the Protein Data Bank and assigned the identifier 4P3Y.
Molecular Modeling—Molecular figures were prepared
using PyMOL Molecular Graphics System, Version 1.6
Schro¨dinger, LLC. Electrostatic surface potential calculations
were carried out in APBS (47). Interaction analysis of the inter-
face residues and the buried surface areawere determinedusing
PISA (48). Molecular modeling and rotamer analysis were per-
formed using Coot model building tools (46), and geometry
idealization was carried out in Phenix.pdbtools (45). Mem-
brane protein topology was analyzed in TOPSCON (49).
EcDsbA Complementation—A chimera gene encoding for a
mature AbDsbA with an E. coli DsbA signal peptide or a wild-
type EcDsbA was cloned under an arabinose-inducible pro-
moter in the pBAD33 plasmid (50). DsbA null E. coli cells
(JCB817; Ref. 51) harboring the EcDsbA/pBAD33 or AbDsbA/
pBAD33 plasmid were spotted onto a soft M63 minimal agar
plate containing 40 mg/ml concentrations of each amino acid
(except L-cysteine) and 0.1% arabinose. Cell swarming was ana-
lyzed after incubating the plates for 4–5 h at 30 °C. The exper-
iment was repeated two times, and the agar plates were
photographed.
Determination of Standard Redox Potential—Oxidized
AbDsbA (2 M) in degassed 100 mM phosphate buffer, pH 7.0,
containing 1mM EDTA and 1mM oxidized glutathione (GSSG)
was incubated with a range of reduced glutathione (GSH) con-
centrations (0.01 M–1 mM) for 24 h at 25 °C. AbDsbA was
precipitated with 10% trichloroacetic acid, and the pellet was
washedwith 100% ice-cold acetone. Free thiols in AbDsbawere
labeled with 4 mM 4-acetamido-4-maleimidylstilbene-2–2-
disulfonate in 50 mM Tris, pH 7.0, and 1% SDS. Reduced and
oxidized forms of AbDsbA were separated on a NuPAGE 12%
Bis-Tris gel (Invitrogen) and stained with Coomassie. Intensi-
ties of the reduced proteinwere analyzed using ImageJ (Version
1.44) (52). The fraction of the reduced protein was plotted
against the ratio of [GSH]2/[GSSG], and the equilibrium con-
stantKeqwas calculated using a binding equation,Z ([GSH]2/
[GSSH])/(Keq  ([GSH]2/[GSSH])), where Z is the fraction of
reduced protein at equilibrium. The redox potential was calcu-
lated using the Nernst equation: E0  EGSH/GSSG0  (RT/nF)ln
Keq, where EGSH/GSSG0 is the standard potential of 240 mV
(53), R is the universal gas constant 8.314 JK1mol1, T is the
absolute temperature in K, n is the number of electrons trans-
ferred, F is the Faraday constant 9.648 104 Cmol1, andKeq is
the equilibrium constant. The redox equilibria measurements
were repeated two times, and the resulting mean values are
plotted including S.D. for each measurement.
Disulfide Reductase Assay—Insulin turbidity as a result of
disulfide bond reduction was monitored using a spectropho-
tometer at 650 nm for 60 min (54). The reaction mixture con-
tained 131M insulin, 10MAbDsbA or EcDsbA or EcDsbC in
100mMphosphate buffer, pH 7.0, containing 0.33mMDTTand
2 mM EDTA. The mean values obtained for each data point
from three repeats are plotted, and the standard deviations are
displayed as error bars.
Cysteine Thiol Oxidation Assay—Labeled synthetic peptide
substrate (CQQGFDGTQNSCK) with a europium DOTA
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) at
the N terminus and a methylcoumarin at the C-terminal lysine
side chain was prepared as previously described (55). The assay
was performed in a 50-l reaction volume in the presence of 2
mM oxidized glutathione or 1.6 M membrane-solubilized
E. coli DsbB (EcDsbB) in a 384-well plate (PerkinElmer Life
Sciences OptiPlate). The reaction mixture contained 50 mM
MES, pH 5.5, 50 mM NaCl, 2 mM EDTA, and 80 or 120 nM
AbDsbAorAbDsbAEF-Tu complex. Disulfide bond formation
of the peptide (7M), which was added at the end to initiate the
reaction, was followed using time-resolved fluorescence with
excitation at 340 nmand emission at 615 nm,with a delay of 150
TABLE 1
Data collection and refinement statistics
Statistics for the highest resolution shell are shown in parentheses. The 100th Mol-
probity (85) percentile is the best among the structures of comparable resolution.
The percentile (bracket) and the number of structures included in the comparison
(N) are given in parentheses within bracket. The two Ramachandran outliers, resi-
dues Asp-142 and Arg-333, were also observed in the previous EF-Tu structure
(PDB ID 1EFC).
Data collection
Wavelength (Å) 0.9537
Resolution range (Å) 74.32–2.15
Higher resolution shell (Å) 2.27-2.15
Space group P 21 21 21
Unit cell
a, b, c (Å) 74.3, 78.2, 122.8
, ,  (°) 90, 90, 90
Total reflections 140,846
Unique reflections 39,200 (5,568)
Multiplicity 3.6 (3.6)
Completeness (%) 99.4 (98.2)
Mean I/ (I) 13.7 (2.5)
R-merge 0.065 (0.596)
R-pim 0.040 (0.366)
Refinement statistics
R-work (%) 17.2 (24.0)
R-free (%) 21.5 (28.0)
No. of non-H atoms
Protein 4,454
Ligands 35
Water 245
Protein residues 567
Root mean square bond lengths (Å) 0.008
Root mean square bond angles (°) 1.12
Ramachandran
Favored (%) 97.0
Outliers (%) 0.3
Average B-factor (Å2) 46.3
Wilson B-factor (Å2) 36.1
Molprobity
Clashscore (percentile) 2.0 [100th (483)]
Score (percentile) 1.16 [100th (10,544)]
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s and reading time of 100s in a Synergy H1multimode plate
reader (Biotek) as described before (56). The reaction in the
absence of enzyme served as the control. The mean values
obtained from three repeat experiments were plotted, and the
S.E. are shown for each data point unless otherwise indicated.
Isothermal Titration Calorimetry (ITC)—Synthetic peptides
were purchased from Genicbio Ltd. Peptides were dissolved in
25 mM HEPES, pH 7.4, 100 mM NaCl (ITC buffer) to obtain 4
mM stock solutions, which were flash-frozen and stored at
80 °C. The isothermal titration experiments were performed
using either a MicrocalTm ITC200 or an autoITC200 (GE
Healthcare). The syringewas loadedwith titrant peptide at con-
centrations of 2 or 4 mM (DsbB P2 peptide) or 200 M (EF-Tu
switch I peptide). The sample cell was loaded with oxidized
AbDsbA with concentrations of 100 M (for titrations with
DsbB P2 peptide) or oxidized/reduced/mixed AbDsbA of 10
M (for titrations with EF-Tu switch I peptide) in ITC buffer.
To assess whether EF-Tu switch I peptide competes for the
DsbB P2 peptide binding site, 100 M oxidized AbDsbA was
incubated with 125 M EF-Tu switch I peptide for 60 min in
ITC buffer before titration with DsbB P2 peptide at 2 mM con-
centration as described above. Titrations were executed at
25 °C using 19 titrations of 2l each separated by 180 s and at a
constant stirring speed of 1000 rpm. A pre-injection of 0.5 l
was performed to limit slow diffusion of titrant into the cell
before the titration, and the corresponding data point was
removed from subsequent analysis. Thermodynamic parame-
ters were obtained from non-linear curve fitting with the
MicroCalTMOrigin software (Version 7.0552) using a 1:1 bind-
ing model. Each titration experiment was repeated twice, and
the resulting mean and standard deviations are tabulated.
RESULTS
AbDsbA Exhibits the Typical Characteristics of a Dithiol
Oxidase—A. baumannii exhibits extensive genetic variation
even among closely related strains due to gene transfer, mobi-
lization of insertion sequences, recombination, gene loss, and
mutation (57). Nevertheless, DsbA is highly conserved with
sequence identities of 99% among 122 A. baumannii strains
analyzed using BLAST against the Uniprot AcinetobacterKnowl-
edgebase. One prominent variation in AbDsbA sequences is
located in the active site CXXC motif of an avirulent (SDF)
strain. Specifically, the active site motif 34CPHC37 in virulent
AYE strain (AbDsbAH36) is substituted for 34CPLC37 in the SDF
strain (AbDsbAL36). Because variations in the active site motif
can directly influence redox potential and disulfide-bond form-
ing activity of DsbA enzymes (58, 59), we measured the redox
potentials of both AbDsbA natural variants (Fig. 1, A and B).
We found that the redox potential of AbDsbAH36 is more oxi-
dizing (101 1.4 mV) than that of AbDsbAL36 redox poten-
tial (134 mV 1.2 mV), comparable to the reported value of
94mV forP. aeruginosaDsbA (PaDsbA) (60). Conversely, the
redox potential of AbDsbAL36 was more similar to the Entero-
bacteriaceae DsbAs (116 to129 mV) (61).
Recombinant expression of a DsbA can rescue themotility of
DsbA null E. coli cells because DsbAs typically have a broad
protein substrate specificity (62, 63). However, we found that
FIGURE 1.Oxidoreductase properties of AbDsbA.A and B, Redox equilibriawith glutathione at pH 7.0 and 25 °C for AbDsbAH36 andAbDsbAL36, respectively.
AbDsbAwas equilibratedwith redox buffer containing various ratios of glutathione to glutathione disulfide. The fraction of reducedDsbAwas fit to a one-site
binding equation using a non-linear regression method to obtain the equilibrium constant Keq as described under “Experimental Procedures.” C, in vivo
disulfide oxidase activity. The ability of DsbA to recognize EcDsbB and EcDsbA substrates was assessed in vivo using non-motile dsbA null E. coli (72). A
representative agar plate shows that expression of AbDsbA (right panel) weakly restores motility of dsbA null E. coli compared with the control EcDsbA (left
panel). The motility zone, indicated by the white bar, was imaged 7 h after inoculating with2 106 cells. In vitro dithiol oxidase activity in the presence of
EcDsbB (D) or oxidized glutathione (E) is shown. Fluorescence increase as a consequence of disulfide bond formation in peptide substrate is monitored. F,
disulfide reductase activity. Enzyme catalyzed or DTT-mediated disulfide reduction causes insulin precipitation, whichwasmonitored spectrophotometrically
at 650nm.Ameanof two (panels A andB) or three (panelsD–F)measurements for eachdatapoint are shown. Error bars indicate theS.D. (A,B, and F) or S.E. (D–E).
Filled circle; AbDsbAH33; empty circle, AbDsbAL33; diamond, EcDsbA; star, EcDsbC; cross, control in the absence of DsbA/DsbC.
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AbDsbA only weakly restores the motility of E. coli DsbA-null
cells in the cell-swarming assay (Fig. 1C).
To assess whether AbDsbA has in vitro disulfide bond-
forming activity, we used a time-resolved fluorescence assay
using a substrate peptide labeled with a europium chelate and a
coumarin donor (see “Experimental Procedures.”). In the pres-
ence of EcDsbB as a source of DsbA oxidant, we found that
AbDsbA enzymes were only marginally active compared with
EcDsbA (Fig. 1D). However, using oxidized glutathione as the
DsbA oxidant (Fig. 1E), we found that AbDsbAL36 and EcDsbA
dithiol oxidase had comparable activity and that AbDsbAH36
was more active again, under the same conditions. These
results suggest that AbDsbA is an oxidase, but it does not inter-
act with EcDsbB.
We then assessed for the ability of AbDsbA to catalyze disul-
fide reduction using insulin as the general substrate in the pres-
ence of dithiothreitol as a mild reducing agent (51). In this
experiment AbDsbAL36 reduced the intermolecular disulfide
bonds of insulinmore rapidly than AbDsbAH36 butmuchmore
slowly than the dedicated disulfide isomerase EcDsbC (Fig. 1F).
The results of these experiments demonstrated that both
variants of AbDsbA are bona fide dithiol oxidases. The data also
indicated that the interaction surface for DsbBmay be different
from that of EcDsbA. The lack of AbDsbA interaction with
EcDsbB was somewhat surprising given that PaDsbA, which
shares 44% sequence identity to AbDsbA, does interact with
EcDsbB (60). However, AbDsbA has a calculated pI of 9.5 com-
pared with 5.8 for PaDsbA, and this may contribute to differing
interaction propensities.
AbDsbA Directly Interacts with EF-Tu—Recombinant His-
tagged AbDsbA (AbDsbAH36, hereafter referred to as AbDsbA,
for simplicity) expressed in the cytoplasm of E. coli and purified
by His-affinity chromatography consistently co-purified with a
40-kDa contaminant thatwe identified as an endogenousE. coli
protein (Fig. 2A). Binding of the E. coli protein by His-immobi-
lized AbDsbA was unchanged up to 1.1 M NaCl or 0.5% v/v
Triton X-100. Even after metal affinity purification, AbDsbA
and the E. coli protein co-eluted as a major fraction in size
exclusion chromatography (Fig. 2B). Analysis of samples in
SDS-PAGE run under non-reducing conditions indicated that
the interaction between AbDsbA and EF-Tu was not thiol-me-
diated (Fig. 2A). Using in-gel digestion and mass spectrometric
analysis, we identified the co-eluant as the E. coli elongation
factor Tu (EF-Tu). Notably, the dithiol oxidase activity of the
AbDsbAEF-Tu 1:1 complex was reduced by 2/3 compared
with the activity of AbDsbA alone (Fig. 2C).
Structure of the AbDsbAEF-TuGDPComplex—To elucidate
the structural basis for the recognition of EF-TubyAbDsbA,we
determined the structure of AbDsbAEF-Tu complex. Before
crystallization the protein complex was purified by size exclu-
sion chromatography. The crystal structure of the complex was
phased by molecular replacement using the coordinates of
E. coli EF-Tu (PDB ID 1EFC) as the search model (Fig. 3A) and
refined to 2.15 Å resolution.
The crystal structure revealed a 1:1 complex and showed that
EF-Tu is captured in its guanosine diphosphate (GDP)-bound
state (Fig. 3, A and E). EF-TuGDP folds into three distinct
domains: the N-terminal guanine nucleotide binding catalytic
domain (Domain 1, also known as the G domain) connected
to 7-stranded and 6-stranded -barrel domains (Domains 2
and 3). The global architecture of EF-TuGDP in complex
with AbDsbA is similar to that of the previously reported
EF-TuGDP structure except for a minor movement of
Domains 2 and 3 and a major local conformational rear-
rangement in the catalytic Domain 1 (Fig. 3, B–C).
Previous structural studies showed that the EF-Tu catalytic
domain can undergo nucleotide-dependent rearrangements
primarily involving two flexible regions, known as switch I (res-
idues 51–65) and switch II (residues 84–100). In the GTP-
FIGURE 2. EF-Tu forms a stable non-covalent interactionwith AbDsbA. A,
His-tagged AbDsbA is co-purified with an endogenous 40-kDa E. coli pro-
tein. Elution fraction pretreated with DTT () or without () pretreatment
was analyzed by SDS-PAGE and stained with Coomassie Blue. B, a major pro-
portion of AbDsbA co-elutes with EF-Tu in size-exclusion chromatography.
FPLC chromatogram shows the analysis of elution fractions from His affinity
purification on superdex200 10/300 GL column. mAU, milliabsorbance units.
C, in vitro dithiol oxidase activity of AbDsbAEF-Tu complex in the presence of
oxidized glutathione. Fluorescence measurement of the dithiol activity of
AbDsbA or AbDsbAEcEF-Tu 1:1 complex (120 nM) was performed as
described under “Experimental Procedures.” Error bars indicate the S.E. of 10
repeats.
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bound form, switch I forms an -helix (PDB ID 1OB2), which
rearranges in the GDP-bound form to a -hairpin (PDB ID
1EFC; Ref. 64) or a disordered segment (PDB ID 1EFU; Ref. 65).
The switch II helix alters both its orientation and length
between these two nucleotide binding states. In contrast, in the
present complex, switch I binds to AbDsbA in an extended
conformation (Fig. 3, B and D), whereas the switch II confor-
mation and the GDP binding mode are as described previously
for EF-TuGDP (PDB ID 1EFC; Ref. 64).
In this complex with EF-Tu, AbDsbA adopts the canonical
DsbA fold comprising a non-contiguous thioredoxin foldwith a
helical domain insertion (Fig. 4A). The AbDsbA structure is
similar to that of PaDsbA with a root mean square deviation of
1.28 Å for 164 C atoms. The structure encompasses a five-
stranded mixed -sheet surrounded by 7 helices (H1-H7) with
the crucial CXXC motif located at the N terminus of helix H1.
Structural comparison of AbDsbA and PaDsbA shows that the
catalytic residues formed by the CXXC (34CPHC37) motif and
the adjacent essential cis-Pro motif (Val150–Pro151) are identi-
cal (Fig. 4B). In AbDsbA, the distance between sulfur atoms of
the first and the second of the two active site cysteinesmeasures
3.6 Å, which falls within the range observed in other reduced
DsbA structures (3.3–3.8 Å). The interatomic distances of key
atoms of the active site residues of AbDsbA are similar to those
of PaDsbA, suggesting that EF-Tu binding does not induce
changes at the AbDsbA active site. Catalytic residues of DsbA
enzymes are surrounded by three surface loops (Fig. 4A): the
3-H2 connecting loop (L1), the H6-4 connecting loop (L2,
the well characterized cis-Pro loop), and the 5-H7 connecting
loop (L3). In E. coli DsbA these three loops create a catalytic
surface targeted by substrate and partner proteins (63, 66, 67).
In the present structure, however, the switch I-mediated EF-Tu
interaction does not engage the catalytic surface but instead
interacts with the solvent-exposed non-catalytic surface of
AbDsbA (see below).
The Positively Charged Non-catalytic Surface of AbDsbA
Engages EF-Tu—We previously identified two DsbA classes
based on the topological arrangements of strand 1: class I
DsbA (3–2-4–5-1) and class II DsbA (1–3-2–4-5) (61).
AbDsbA falls into the class I topology, with 1 forming hydro-
gen bonds to5, creating a-sheet topology of 3–2-4–5-1. The
structural consequence of the class I DsbA topology (Fig. 4C) is
the formation of a large groove between the thioredoxin and
helical domains on the non-catalytic surface. This groove is
truncated in the class II DsbAs in which 1 interacts with 3.
The surface shape and electrostatic features of the non-cat-
alytic surface groove are variable among class I DsbAmembers
(Fig. 4, D–G). In AbDsbA, the non-catalytic surface groove has
a distinct positive electrostatic potential, and it is this region
that is engaged by the EF-Tu switch I segment (Fig. 4G).
FIGURE 3. Switch I region of EF-Tu binds to AbDsbA. A, crystal structure reveals AbDsbAEF-Tu forms 1:1 complex. EF-Tu is comprised of three domains with
GDP (orange sphere) andMg2 (gray sphere) binding to its guanosine bindingDomain 1. AbDsbA is shown inmediumblue. B, EF-Tu undergoes conformational
changes in associationwithAbDsbA. Structural superpositionofGDP-bound states of EF-Tu (blue) in complexwithAbDsbAandpreviously reported EF-Tu (red,
PDB ID 1EFC) is shown. EF-Tu alignment relative toDomain 1 showsmovements in Domains 2 and 3. Conformations of switch I and switch II regions are shown
in different color shades (Switch I: yellow, AbDsbAEF-Tu; green, EF-Tu; Switch II: black, AbDsbAEF-Tu; white, EF-Tu). C, minimal conformational change within
EF-Tu domain 2 and 3. Shown is the comparison of domain 2–3 of EF-Tu in the complex structure (blue) with previous EF-Tu structure (red). 2mFo DFc maps
are displayed at 1.0  contour around switch I segment (cyan) (D) and GDPMg2 (E).
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Analysis of the interactions between the two proteins
shows that the EF-Tu switch I segment (residues 47–56) adopts
an extended conformation, occupying the groove between
H1-to-3 and H3 on the non-catalytic surface of AbDsbA (Fig.
5A). The C terminus of switch I (residues 51–56) forms exten-
sive hydrogen bonds and electrostatic interactions with four
basic residues (Arg-56, Arg-59, Arg-84, Lys-85) and a polar res-
idue (Gln-45) of AbDsbA (Fig. 5B). Asp-51 at the center of the
EF-Tu switch I segment makes contact with five AbDsbA resi-
dues in the groove. In addition, EF-Tu residues Phe-47, Gln-49,
Ala-53, and Pro-54 form van der Waals contact with Leu-48,
Ile-51, His-88, Leu-89, Pro-90, and His-93 of AbDsbA. These
polar and hydrophobic interactions bury 40% (683 Å2) of the
solvent-accessible surface area of the EF-Tu switch I segment
(residues 47–56).
On the basis of this structurally characterized interaction, we
designed an 11-residue peptide derived from the E. coli EF-Tu
switch I sequence and assessed its binding to AbDsbA using
ITC. The binding study showed that the switch I peptide seg-
ment (46AFDQIDAPEE56) binds to AbDsbA with an affinity
range of 74–162 nM (Table 2). Binding of the switch I peptide is
unaffected by the redox status of AbDsbA. In contrast, we did
not detect binding of this same switch I peptide to EcDsbA
under the same conditions.
We also investigated whether EF-Tu from A. baumannii
(AbEF-Tu)might interact withAbDsbA. Sequence comparison
of switch I of E. coli EF-Tu with that of AbEF-Tu showed that
the two sequences are similar but not identical (Table 2). Posi-
tions 1 and 3 of EcEF-Tu switch I are not conserved in AbEF-
Tu, but neither of these residues interacts with AbDsbA in the
FIGURE 4.AbDsbA and other DsbA I enzymes have a large groove on the non-catalytic surface. A, structural overlay of AbDsbA (blue/violet) and PaDsbA
(gold/green). DsbA contains a TRX-domain (bottom) and a helical domain (top) with the domains identified by different colors. Secondary structural elements
are annotated, and the catalytic cysteines are shownasgreen spheres. B, structural superposition of catalytic sites of AbDsbAandPaDsbA.C, AbDsbA shares the
same-sheet topology (3–2-4–5-1) as theDsbA I enzymes (61). The switch I peptide segment of EF-Tu binds to the non-catalytic surface groove created at the
interdomain space of AbDsbA. D–G, the non-catalytic groove on the DsbA I enzymes has a charged surface. Electrostatic surface potentials of B. pseudomallei
DsbA (D), EcDsbA (E), PaDsbA (F), andAbDsbA (G) are contouredbetween6.0 (red) and6.0 (blue) kT/e. The shapeof thenon-catalytic surfacegroove (located
on the surface opposite to the catalytic site) and the electrostatic potential was not conserved among DsbA I enzymes. The switch I peptide segment of EF-Tu
binds to the positively charged non-catalytic surface groove of AbDsbA.NeisseriameningitidisDsbA3 (PDB ID 3DVX) is the only other structurally characterized
DsbA that has a positive potential in this region.
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crystal structure (Fig. 5).However, Asn at position 7 of EcEF-Tu
does interact with Gln-45 of AbDsbA, and this residue is
replaced by Ser in AbEF-Tu. Side-chain modeling suggested
that substitution of Asn for Ser at position 7 should maintain
the hydrogen bond interaction with Gln-45 of AbDsbA. As
expected, the switch I peptide of AbEF-Tu did bind toAbDsbA,
although with a 3-fold reduced affinity of 500 nM compared
with the EcEF-Tu peptide (Table 2). Removal of the 3 residues
at the N terminus of the AbEF-Tu switch I peptide reduced
binding by a further 3.5-fold, suggesting that the interaction
of Phe/Tyr at position 2withHis93 ofAbDsbA is very favorable.
AbDsbA Binds a Peptide Derived from AbDsbB—Dithiol oxi-
dase activity of AbDsbA relies on interaction with the redox
cycling enzyme DsbB (Fig. 1, D–E). Structural studies of
EcDsbAEcDsbB complex revealed that a transient interaction
between the cysteine-containing second periplasmic loop (P2)
of the 4-helix bundle protein EcDsbB and the surface surround-
ing the catalytic cysteine of EcDsbA is responsible formaintain-
ing EcDsbA in a functionally active oxidized state. The interac-
tion of EcDsbAwith EcDsbB is mediated in part by three loops,
L1, L2, and L3, that define the catalytic surface. In AbDsbA, the
L1 loop comprises five residues and is conformationally similar
to that of P. aeruginosa DsbA (Fig. 4A), whereas the L3 loop is
much shorter in AbDsbA, formed from just 3 residues (Gln162–
Gly163–Glu164). As a consequence, AbDsbA has small discon-
tinuous pockets (50 Å3) on the catalytic surface between the
cis-Pro loop (L2) and L3 as opposed to a large continuous
groove found in this region in EcDsbA.
The A. baumannii genome encodes for a protein homolo-
gous to EcDsbB (25% sequence identity, Uniprot: B0V9V0).
The high secondary structural similarity of the predicted trans-
membrane helical regions suggested that the putative AbDsbB
retains the same four-helix topology as EcDsbB with two loops
pointing into the periplasm.
FIGURE 5. Analysis of the interaction between EF-Tu and AbDsbA. A, location of the bound EF-Tu switch I region on the non-catalytic surface of AbDsbA.
Both the EF-Tu switch I residues (Phe-47–Glu-56) and the ADsbA residues (on H1, H3, 3, and the connecting loop between H1 and 3) contributing to the
interaction are shown as sticks. B, details of EF-Tu switch I interaction with AbDsbA. The C terminus of EF-Tu switch I (green, Asp-51–Glu-56) forms the key
hydrophilic and electrostatic interactions with AbDsbA. EF-Tu residues are labeled in blue; AbDsbA residues are labeled in black (hydrophobic interaction) or
red (polar interaction). Interactions of the cis-Pro loop of E. coliDsbAwith the P2 loop of E. coliDsbB (C) and similar interactions observed at the AbDsbA cis-Pro
loop with a symmetry-relatedmolecule of EF-Tu (domain 2) in the crystal structure (D) are shown. Potential hydrogen-bond interactions are shown as dashed
lines. Cysteine thiols are shown as green spheres.
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In the structure of the EcDsbAEcDsbB complex, Cys-104
from the EcDsbB P2 loop segment (98PSPFATCDFM107) forms
a mixed disulfide bond with catalytic residue Cys-30 of
EcDsbA, and other residues form hydrophobic interactions
and three hydrogen bonds with the cis-Pro loop (Fig. 5C).
The corresponding P2 loop of AbDsbB comprises residues
95PDQVPSCGPG104.
Analyzing the crystallographic packing interface of the
AbDsbAEcEF-Tu complex showed that residues 262RKLLD266
of a neighboring EF-Tu domain 2 interact with the catalytic
surface of AbDsbA, placing the EF-Tu Leu-264 side chain very
close to the catalytic cysteine of AbDsbA (3.8 Å from Cys-34
S). Hydrogen bond interactions are formed between EF-Tu
Leu-264 and Asp-266 and the AbDsbA cis-Pro loop in a man-
ner similar to that observed between the EcDsbA cis-Pro loop
and the P2 loop of the EcDsbADsbB crystal structure (Fig. 5D).
Modeling theAbDsbB P2 loop segment onto the observed crys-
tal structure conformation of EF-TuRKLLD residues suggested
that 7–8 AbDsbB residues could bind to the catalytic surface of
AbDsbA. On the basis of this molecular model, we designed a
heptapeptide (PSCGPGL) from the AbDsbB P2 sequence and
showed that it bound to AbDsbA with a KD of 7.9 M (Table 2).
Similar to a previous study (56), binding of the AbDsbB peptide
is cysteine-dependent in that substitution of Cys for Leu in
the peptide eliminated binding. Importantly, binding of the
AbDsbB P2 peptide to AbDsbA is independent of EF-Tu pep-
tide binding, supporting the notion that EF-Tu and AbDsbB
bind to AbDsbA at distinct sites (Table 2).
DISCUSSION
Multidrug resistant A. baumannii is emerging as an agent of
serious nosocomial and community-acquired infection (68).
The current economic loss of preventable hospital-acquired
infections ($5.7–6.7 billion) is now comparable to the costs of
stroke ($6.7 billion), diabetes mellitus ($4.5 billion), and
chronic obstructive lung disease ($4.2 billion) in the United
States (69). Anti-virulence therapy is an attractive strategy to
combat rapidly spreading infections caused by multidrug-re-
sistant A. baumannii (28, 70, 71).
Studies from animal models suggested that the absence of
DsbA or DsbB attenuates infection and pathogenesis of Gram-
negative bacteria (23, 24, 73). Because DsbA/B is not essential
for bacterial survival (51) but is required for virulence (17),
DsbA/B is a target for the development of novel anti-virulence
agents against Gram-negative bacteria (17). For example, bio-
film formation is essential for colonization and infection by
A. baumannii (13, 74, 75). Interference with this process by
inhibiting DsbA could impair the ability of bacteria to establish
infection.
Our characterization of AbDsbA showed that it is a member
of the DsbA Ib sub-class, which also includes DsbAs fromNeis-
seria and Pseudomonas (61). Using ITC, we demonstrated that
an AbDsbB-derived peptide binds to AbDsbA via its catalytic
cysteine, supporting the idea that DsbA and DsbB form a func-
tional redox pair in A. baumannii. The absence of an interac-
tion between AbDsbA and EcDsbB suggests that the truncated
catalytic surface of AbDsbAmay engage AbDsbB by a different
binding mode to that described for EcDsbB and EcDsbA.
We also reported the detailed interaction between AbDsbA
and EF-Tu. EF-Tu is highly conserved (85% sequence identity
between AbEF-Tu and EcEF-Tu) and is best known for its cat-
alytic role in the elongation cycle of bacterial protein synthesis.
However, EF-Tu also acts as a response protein in abiotic and
biotic stresses (76, 77), and it has roles in biofilm development
(78) and immunospecific immunity (79). EF-Tu is generally
considered to be a cytoplasmic protein, but there is evidence for
localization on the surface and outermembrane vesicles of bac-
teria (29, 80, 81). It is also a relatively ubiquitous interactor with
other proteins (actin like MreB (33) and fibronectin (32)). The
association between AbDsbA and EF-Tu provides new avenues
for understanding the interaction of EF-Tuwith other proteins;
for example, the Switch I region may interact tightly with cyto-
plasmic proteins that exhibit similarly strong positive surface
TABLE 2
Thermodynamic parameters for peptides derived from EF-Tu or AbDsbB binding to AbDsbA or EeDsbA
KD is apparent dissociation constant, 	H is enthalpy change, T is absolute temperature (K), 	S is entropy change, N is apparent stoichiometry, and n.b. is no detectable
binding.T	S is calculated from the free energy equation (	G	H T	SRT ln KD). The averaged values from two ITC experiments are tabulated with standard
deviation. A. baumannii EF-Tu-derived peptides are differentiated from EcEF-Tu peptides by grey shading. The redox status of AbDsbA used in the titration experiment
is identified by: ox, oxidized; red, reduced; mix, mixed.
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charge. The switch I region is also the binding site for other
proteins including ribosome (82). The PDB entry 4IW3 (yet to
be published) shows the EF-Tu switch I region interacts with
Pseudomonas putida prolyl-4-hydroxylase, although in a some-
what different conformation. Overall, these data suggest that
the switch I region of EF-Tu is a flexible protein interaction
loop.
It is tempting to speculate a physiological/pathological role
for the association between AbDsbA and EF-Tu that might
involve regulation of cell growth in response to nutrient depri-
vation or oxidative stress in the host environment or chaperon-
ing of EF-Tu by AbDsbA. Both AbDsbA and EF-Tu are impor-
tant proteins in their own right, and both have been identified
as antibacterial targets. Although we showed that AbEF-Tu-
derived peptides do bind to AbDsbA, we have no direct evi-
dence for an AbDsbAAbEF-Tu interaction in A. baumannii.
Consequently, we cannot rule out the possibility that the inter-
action between EcEF-Tu and AbDsbA is simply an artifact.
Nevertheless, the detailed interactions derived from the
AbDsbAEF-Tu structure provides a potential new approach
for AbDsbA inhibitor development. TheDsbA catalytic surface
is widely accepted as the major target surface for substrate/
partner protein interactions (63, 66, 67). This interaction is
essential for formation of intermediate mixed disulfides with
substrate proteins. However, the non-catalytic surfacemay also
contribute to the folding of substrates or to the interactionwith
as-yet unidentified regulatory proteins.
Members of class I DsbAs all have a large charged non-cata-
lytic surface groove (Fig. 4, D–G). In EcDsbA the equivalent
acidic surface was identified several decades ago as a potential
interaction site (83). The variable molecular landscape and
nature of this surface among DsbAs may reflect the extraordi-
nary variability of substrates (61, 84). The high resolution struc-
ture of the AbDsbAEcEF-Tu complex supports the idea that
the pronounced non-catalytic surface groove of class I DsbA
enzymes serves as an additional protein interaction site.
Whether or not this is the case remains to be elucidated. Nev-
ertheless, the reduced activity of AbDsbA in the presence of
bound EcEF-Tu suggests compounds designed to target this
non-catalytic site would inhibit AbDsbA enzyme activity.
In summary, we have characterized AbDsbA and identified
two peptides that bind to non-overlapping AbDsbA surfaces.
These distinct peptides provide the starting point for peptide-
based inhibitors targeting AbDsbA activity.
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